GlassScriptPhysician profile
David G Hurrell
NPI 1194784835
$204,949.36
in general payments reported to CMS, 2019-2025
5 companies · $29K in 2025
The $29K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $34K · 2021: $51K · 2022: $31K · 2023: $19K · 2024: $9,103 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $58K · Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,525.00 |
| Food and Beverage | $102.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $204,800.00 | 2019-2025 | Clinical Trial Product |
| Alnylam Pharmaceuticals INC. | $73.20 | 2024 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $29.77 | 2024 | Wainua |
| Akcea Therapeutics, INC. | $27.11 | 2019 | |
| Abbott Laboratories | $19.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hurrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.